Novartis’ experimental cancer treatment wins endorsement of FDA advisers
The U.S. Food & Drug Administration (FDA) on Wednesday endorsed a first-of-its-kind cancer treatment that makes use of patients’ revved-up immune cells to fight back the deadly disease.
Advisers to the FDA recommended approval of a new experimental cancer treatment called CAR-T therapy for kids with leukemia. The new treatment retrains the patient’s immune system to kill tumor cells.
Oncologic Drugs Advisory Committee member Timothy Cripe, an oncologist with Nationwide Children’s Hospital in Ohio, said the recommendation for the treatment was the most exciting thing she had seen in her lifetime.
However, Dr. Wilson Bryan, who directs the agency’s office that oversees these kinds of treatments, said it would be difficult to standardize.
Commenting on the treatment, Dr. Bryan said, “Particularly, we are concerned that the same safety and benefit seen in clinical trials may not translate into routine use. This is a complex product.”
The recommendation from the federal agency’s Oncologic Drugs Advisory Committee indicates that Novartis’ experimental treatment can be approved by the agency by the end of September this year.
Fashion major Michael Kors has agreed to acquire Jimmy Choo for $1.2 billion. New York-based Michael Kors will be able to diversify its portfolio by acquiring UK-based Jimmy Choo, a brand having strong sales in luxury segment.
Samsung is yet to officially unveil its next-generation flagship Galaxy Note 8 smartphone, but KGI Securities analyst Ming-Chi Kuo has already revealed some key details of the upcoming device’s dual camera setup.
Some employees of a tech firm in Wisconsin will soon be able to open doors, unlock office equipment, log into computers and even make in-house purchases with just a swipe of the hand.
The International Monetary Fund (IMF) has predicted US and UK economies will experience weaker-than-expected activity and expand more slowly this year than previously predicted.
The European Commission has confirmed that EU antitrust regulators are probing allegations of a cartel among a group of German carmakers, in an action that could result in bulky penalties for the companies.
Tesla Motors’ long-awaited Model 3 will be a “major test” for the Palo Alto-based electric car giant, according to industry analysts.